Heaven and hell-a phenomenological study of recreational use of 4-HO-MET in Sweden

Journal of Psychoactive Drugs

Volumn 43, Issue 3, 2011, Pages 211-219

  Kjellgren, Anette ^a   Soussan, Christophe ^a  

^a KARLSTAD UNIVERSITY   (Sweden)

Author keywords

4 HO MET; Hallucinogen; Internet drug; Legal high; Psychedelic; Research chemical

Indexed keywords

4 HYDROXY N METHYL N ETHYLTRYPTAMINE; LYSERGIDE; PSILOCYBINE; PSYCHEDELIC AGENT; RECREATIONAL DRUG; UNCLASSIFIED DRUG; STREET DRUG; TRYPTAMINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; DRUG ABUSE; DRUG EFFECT; EMOTIONAL STABILITY; EXPECTATION; FUNCTIONAL STATUS; HUMAN; INTERNET; MOTIVATION; PERCEPTIVE DISCRIMINATION; SWEDEN; ADOLESCENT; ATTITUDE TO HEALTH; AWARENESS; CONSUMER; EMOTION; FEMALE; MALE; MENTAL FUNCTION; PERCEPTION; QUALITATIVE RESEARCH;

ADOLESCENT; ADULT; AWARENESS; COGNITION; CONSUMER SATISFACTION; EMOTIONS; FEMALE; HALLUCINOGENS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; MALE; MENTAL PROCESSES; MOTIVATION; PERCEPTION; QUALITATIVE RESEARCH; STREET DRUGS; SWEDEN; TRYPTAMINES; YOUNG ADULT;

EID: 84856392858     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2011.605699     Document Type: Article

References (30)

1. Asenlöf, K.; Olsson, S.; Bood, S. & Aring;. & Norlander, T. 2007. Case studies on fibromyalgia and burn-out depression using psychotherapy in combination with flotation-REST: Personality development and increased well-being. Imagination, Cognition and Personality 26 (3): 259-71.
2. Babu, K.; Boyer, E.W.; Hernon, C. & Brush, E. 2005. Emerging drugs of abuse. Pediatric Emergency Medicine 6 (2): 81-84.
3. Camilleri, A.; Johnston, M.R.; Brennan, M.; Davis, S. & Caldicott, D.G.E. 2010. Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, a-phthalimidopropiophenone and Nethylcathinone. Forensic Science International 197: 59-66.
4. De Bono, E. 1970. Lateral Thinking: Creativity Step By Step. New York: Harper & Row.
5. Doblin, R.E. 2000. The regulation of the medical use of psychedelics and marijuana. Doctorial dissertation Harvard University Cambridge, Massachusetts.
6. Edebol, H.; Bood, S. & Aring;. & Norlander, T. 2008. Case studies on chronic whiplash associated disorders and their treatment using flotation-REST (Restricted Environmental Stimulation technique). Qualitative Health Research 18, 480-88.
7. Erowid. 2010. Tryptamine-FAQ. Available at: http://www.erowid.org/psychoactives/research_chems/
8. European Monitoring Centre for Drugs and Drug Addiction (EMCDD). 2010. New drugs and emerging trends. The State of the Drugs Problem in Europe. Annual Report 2010. Available at: http://www. emcdda.europa.eu/attachements.cfm/att_120104_EN_EMCDDA_ AR2010_EN.pdf
9. Griffiths, R.R. & Grob, C.S. 2010. Hallucinogens as medicine. Scientific American 12: 76-79.
10. Grof, S. 1980. LSD Psychotherapy. Alameda, CA: Hunter House.
11. Hopkins Tanne, J. 2004. Humphry Osmond. British Medical Journal 328: 713.
12. Hultén, P. 2010. Internetdroger-Faror som lurar i missbruksvärlden [Internet drugs-Dangers in the drug abuse world]. Örebro: SeminariumD10 Drogfokus. Available at: http://www. drogfokus2010.se/drogfokus2010/filer/Seminarium_D10_-_Nya_ Internetdroger___faror_som_lurar_i_missbruksvarlden.pdf [Swedish]
13. Karlsson, G. 1995. Psychological Qualitative Research from a Phenomenological Perspective. Stockholm: Almqvist & Wiksell International.
14. Kjellgren, A.; Eriksson, A. & Norlander, T. 2009. Experiences of encounters with ayahuasca-"the vine of the soul. " Journal of Psychoactive Drugs 41 (4): 309-15.
15. Luna, L.E. & Amaringo, P.C. 1993. Ayahuasca Visions-The Religious Iconography of a Peruvian Shaman. Berkeley: North Atlantic Books.
16. Metzner, R. 1998. Hallucinogenic drugs and plants in psychotherapy and shamanism. Journal of Psychoactive Drugs 30: 333-41.
17. Morris, K. 2008. Research on psychedelics moves into the mainstream. Lancet 371: 1491-92.
18. Nichols, D.E. 2004. Hallucinogens. Pharmacology & Therapeutics 101: 131-81.
19. Nutt, D.J.; King, L.A. & Phillips, L.D. 2010. Drug harms in the UK: A multicriteria decision analysis on behalf of the Independent Scientific Committee on Drugs. Lancet 376: 1558-65.
20. Passie, T.; Seifert, J.; Schneider, U. & Emrich, H.M. 2002. The pharmacology of psilocybin. Addiction Biology 7: 357-64.
21. Sanders, B.; Lankenau, S.E.; Jackson Bloom, J. & Hathazi, D. 2008. "Research chemicals": tryptamine and phenethylamine use among high-risk youth. Substance Use Misuse 43 (3-4) 389-402. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536767/
22. Schmidt, M.M.; Sharma, A.; Schifano, F. & Feinman, C. 2011. Legal highs on the net-Evaluation of UK-based websites, products and product information. Forensic Science International 206 (1-3): 92-97.
23. Sessa, B.J. 2008. Are psychedelic drug treatment seeing a comeback in psychiatry? Progress in Neurology and Psychiatry 12 (8): 5-10.
24. Shulgin, A. & Shulgin, A. 1997. Tihkal-The Continuation. Berkeley, CA: TransformPress.
25. Shulgin, A. & Shulgin, A. 1995. Pihkal-A Chemical Love Story. Berkeley, CA: TransformPress.
26. Vardaku, I.; Pistos, C. & Spiliopoulou, Ch. 2010. Drugs for youth via Internet and the example of mephedrone. Toxicology Letters doi:10.1016/j.toxlet.2010.12.014
27. Wax, P.M. 2002. Just a click away: Recreational drug web sites on the Internet. Pediatrics 109: e96.
28. Weil A. 1998. The Natural Mind. New York: Houghton Mifflin Company.
29. Wikipedia. 2010. 4-HO-MET: Available at: http://sv.wikipedia.org/wiki/ 4-HO-MET
30. Wohlfarth, A. & Weinmann W. 2010. Bioanalysis of new designer drugs. Bioanalysis 2 (5): 965-79. Retrieved 30 dec 2010 from http://www.ncbi.nlm.nih.gov/pubmed/21083227